Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fnut.2026.1848682.s006BackgroundTraumatic brain injury (TBI) affects 69 million individuals annually and represents a major global health burden. Ketogenic interventions have emerged as a potential therapy to address deficits following TBI. This scoping review updates previous work to synthesize evidence on ketogenic therapies for TBI, examining mechanistic insights, clinical feasibility, and barriers.MethodsA systematic search was conducted following the methodological framework of Arksey and O’Malley (2005) and JBI guidance. Findings are reported in accordance with PRISMA 2020 guidelines complemented by the PRISMA Extension for Scoping Reviews (PRISMA-ScR). Studies were included if they used TBI models in human or animal subjects; investigated ketogenic interventions; reported quantitative clinical, functional, or metabolic outcomes; and enrolled more than five participants in clinical trials. Studies were excluded if they were conducted in vitro, did not involve TBI or ketogenic interventions, were not original research, were duplicate publications, or lacked English full text manuscripts.ResultsOut of 421 studies screened, 32 studies met the inclusion criteria. 25 animal studies and 7 human studies were analyzed. 68.0% of animal studies used exclusively male specimens. The total pooled male-to-female ratio across human studies was 53:24, reflecting an approximately twofold predominance of male participants. Studies were evaluated using clusters of the most-assessed frameworks. Animal investigations evaluated metabolic pathways in 23 out of 25 (92.0%) studies, neuroprotective effects in 15 out of 25 (60.0%) studies, and behavioral assays in 13 out of 25 (52.0%) studies. Human studies assessed feasibility in 7 out of 7 (100%) studies, safety in 5 out of 7 (83.33%) studies, and efficacy in 4 out of 7 (66.67%) studies. Clinical trials consistently demonstrated feasibility in monitored settings.ConclusionKetogenic interventions improve metabolic dysfunction in preclinical models with variable neuroprotective and functional effects. Clinical evidence demonstrates feasibility but lacks adequately powered efficacy trials. Larger controlled trials with standardized endpoints with balanced age and sex representation are needed to determine efficacy.
Keyword(s):
Clinical and Sports Nutrition; evidence mapping; exogenous ketones; ketogenic diet; ketogenic intervention.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)